Researchers identify a treatment for a rare bone loss disorder that might also lead to help for aging brittle bones
A possible ‘first-line’ treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Hajdu-Cheney syndrome is a rare genetic disease that leads to severe osteoporosis and developmental defects, including the reabsorption of bones in the hands and feet. The disease is associated with mutations in a particular gene, called NOTCH2, which codes for proteins involved with bone maintenance. The NOTCH2 proteins usually help balance destruction and construction essential for bone maintenance and repair. Mutations associated with Hajdu-Cheney syndrome upset that balance, but the exact mechanisms causing bone resorption have not been well understood.
Now, through a series of detailed tests, molecular biologist Hiroyuki Inuzuka and his colleagues have worked out the specific molecular pathway that results in Hajdu-Cheney syndrome.
They found that this particular NOTCH2 mutation does not maintain normal NOTCH2 protein abundance, with the help of another protein, called FBW7. To discover this, the researchers knocked out the gene for Fbw7 in the bones of mice. Without the gene and resulting protein, the mice had severe osteoporosis, much like people with Hajdu-Cheney syndrome — indicating that FBW7 is the primary regulator of this system.
They further determined that in humans with Hajdu-Cheney syndrome, the FBW7 protein was unable to bind to NOTCH2 proteins because the binding spot is missing in osteoclasts. This mutation allows the osteoclasts to over-operate, breaking down too much bone tissue.
The researchers were able to reverse bone loss in the knock-out mice with the elevated NOTCH2 by giving them a medication that blocks osteoclast formation. They tried several different treatments, including a chemical compound called DAPT that was particularly effective. DAPT has been shown to help with osteoarthritis by inhibiting function of NOTCH proteins in other studies. Using DAPT as well as Zoledronic acid, a common medication for osteoporosis, “may become a first-line treatment for Hadju-Cheney syndrome,” the researchers conclude in their study.
“By clearly identifying the relationship between FBW7 and NOTCH2 proteins, we have identified potential therapeutic targets for patients with rare bone diseases as well as much more widespread age-related osteoporosis,” said Inuzuka.
Learn more: Reversing severe bone loss
The Latest on: Bone loss
via Google News
The Latest on: Bone loss
- Younger Breast Cancer Survivors Suffer More Bone Loss From Treatment on December 11, 2018 at 2:40 pm
TUESDAY, Dec. 11, 2018 (HealthDay News) -- Younger breast cancer survivors are at increased risk for osteoporosis -- weak, brittle bones -- due to breast cancer treatments, new study finds. The study ... […]
- Bone Loss Isn't Just for Women—Here's How to Tell If You Have It, Too on December 7, 2018 at 10:20 pm
Think that young guys aren't at risk of developing osteoporosis? Think again When you hear the term “osteopenia,” you’re probably wondering, “Does that have anything to do with osteoporosis? Don’t onl... […]
- DHEA therapy may help prevent bone loss and increase muscle mass in older women on December 4, 2018 at 10:22 pm
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone (DHEA) may help prevent bone loss and increase muscle mass in older women, accordi... […]
- Nigeria: Yam Validated to Treat Cancer, Diabetes, Pain, Bone Loss, Others on November 16, 2018 at 10:43 am
Can extracts of the tubers and leaves of some species of yam be used to beat cancer, diabetes, pain, arthritis, bone loss, and premenopausal syndrome? Researchers say the tuber of yam (Dioscorea escul... […]
- Immune culprits linked to inflammation and bone loss in gum disease identified on October 17, 2018 at 6:58 pm
An unhealthy population of microbes in the mouth triggers specialized immune cells that inflame and destroy tissues, leading to the type of bone loss associated with a severe form of gum disease, acco... […]
- Osteoporosis Drug Given By IV May Greatly Lowers Risk Of Fractures For Women In Earlier Stages Of Bone Loss on October 2, 2018 at 5:58 am
"I think it's a breakthrough," Clifford Rosen, an endocrinologist and physician, said of the study. While researchers have known that older women with osteoporosis benefit from drugs called bisphospho... […]
- CHLA Receives $2.3M to Study Bone Loss Tied to Cerebral Palsy on September 18, 2018 at 11:59 am
A researcher at Children’s Hospital Los Angeles has received a $2.3 million federal grant to study bone loss associated with cerebral palsy, the hospital announced Sept. 18. The Eunice Kennedy Shriver ... […]
- Can community exercise prevent bone loss from weight loss in older adults? on August 8, 2018 at 1:20 am
In a Journal of Bone and Mineral Research study of older adults with obesity who were cutting calories, an intervention that incorporated resistance training, aerobic training, or neither did not prev... […]
- Understanding bone loss and how to prevent osteoporosis on July 31, 2018 at 3:10 am
In the United States, osteoporosis affects 80 percent of women and 60 percent of men ages 65 years and older. With growing average life expectancy, osteoporosis screening and treatment is becoming inc... […]
via Bing News